Triple

T4131819
Position Surface form Disambiguated ID Type / Status
Subject oseltamivir E85057 entity
Predicate approvedBy P807 FINISHED
Object U.S. Food and Drug Administration E13297 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: U.S. Food and Drug Administration | Statement: [oseltamivir, approvedBy, U.S. Food and Drug Administration]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: U.S. Food and Drug Administration
Context triple: [oseltamivir, approvedBy, U.S. Food and Drug Administration]
  • A. Food and Drug Administration chosen
    The Food and Drug Administration is a U.S. federal agency responsible for protecting public health by regulating food, drugs, medical devices, and other consumer products.
  • B. Center for Biologics Evaluation and Research
    The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
  • C. Center for Drug Evaluation and Research
    The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
  • D. Office of Regulatory Affairs
    The Office of Regulatory Affairs is the U.S. FDA’s primary field organization responsible for inspecting regulated products and manufacturers, enforcing compliance, and overseeing import operations to protect public health.
  • E. FDA CFSAN
    FDA CFSAN is the U.S. Food and Drug Administration’s center responsible for regulating the safety, labeling, and nutritional quality of foods, dietary supplements, and cosmetics.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69aed935ccd881909dc61f81bcdb7a78 completed March 9, 2026, 2:29 p.m.
NER Named-entity recognition batch_69af022f55fc81909f2a1a04d0ea59e6 completed March 9, 2026, 5:23 p.m.
NED1 Entity disambiguation (via context triple) batch_69b5db72503c81909e9cf69f23d093fc completed March 14, 2026, 10:04 p.m.
Created at: March 9, 2026, 3:42 p.m.